Evidence map›Paper›PMID 22912412›Full record

ArticleDevelopment (Cambridge, England)2012

Germline potential of parthenogenetic haploid mouse embryonic stem cells.

Martin Leeb, Rachael Walker, Bill Mansfield, Jenny Nichols, Austin Smith, Anton Wutz

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Characterizing Marine Medaka (Animals : an open access journal from MDPI · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. A preview of selected articles.Stem cells translational medicine · 2021
    Article
  7. Article
  8. Article
  9. Reproduction reimagined.F&S reports · 2020
    Article
  10. Review
  11. The milestone of genetic screening: Mammalian haploid cells.Computational and structural biotechnology journal · 2020
    Review
  12. Article
  13. Article
  14. Mammalian haploid stem cells: establishment, engineering and applications.Cellular and molecular life sciences : CMLS · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin LeebCentre for Stem Cell Research, Wellcome Trust and Medical Research Council Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK. ml553@cam.ac.uk
Rachael Walker
Bill Mansfield
Jenny Nichols
Austin Smith
Anton Wutz

Funding

Medical Research Council G0800784Medical Research Council G1001028Medical Research Council G1100526Wellcome Trust 079249Wellcome Trust 087530Wellcome Trust 087530/Z/08/A
6 · The paper itself

Abstract

Haploid embryonic stem cells (ESCs) have recently been derived from parthenogenetic mouse embryos and offer new possibilities for genetic screens. The ability of haploid ESCs to give rise to a wide range of differentiated cell types in the embryo and in vitro has been demonstrated. However, it has remained unclear whether haploid ESCs can contribute to the germline. Here, we show that parthenogenetic haploid ESCs at high passage have robust germline competence enabling the production of transgenic mouse strains from genetically modified haploid ESCs. We also show that differentiation of haploid ESCs in the embryo correlates with the gain of a diploid karyotype and that diploidisation is the result of endoreduplication and not cell fusion. By contrast, we find that a haploid karyotype is maintained when differentiation to an extra-embryonic fate is forced by induction of Gata6.

Indexed as

HaploidyAnimalsCell DifferentiationDiploidyEmbryonic Stem CellsKaryotypeMiceMice, TransgenicParthenogenesis

Identifiers

PMID22912412
PMCPMC3424041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.